Arthur He
Stock Analyst at HC Wainwright & Co.
(0)
# 5060
Out of 5,356 analysts
84
Total ratings
26.92%
Success rate
-33.00%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VERA Vera Therapeutics | Maintains: Strong Buy | 75 85 | 30.58 | 177.96% | 2 | Jun 2, 2025 | |
PRME Prime Medicine | Downgrades: Neutral | n/a | n/a | n/a | 8 | May 20, 2025 | |
ADAG Adagene | Reiterates: Buy | 8 8 | 1.77 | 351.98% | 10 | Apr 3, 2025 | |
ADAP Adaptimmune Therapeu... | Maintains: Buy | 4 3 | 0.29 | 934.48% | 6 | Apr 1, 2025 | |
BCAB BioAtla | Reiterates: Neutral | n/a | n/a | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 1.29 | 16.28% | 10 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 7 7 | 0.67 | 870.15% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 16 20 | 4.23 | 372.81% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 9 | n/a | n/a | 17 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 39 | n/a | n/a | 4 | May 28, 2024 |